These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20460398)

  • 1. Antiviral therapy for hepatitis C: why are so few patients being treated?
    Volk ML
    J Antimicrob Chemother; 2010 Jul; 65(7):1327-9. PubMed ID: 20460398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
    de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW;
    Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An update on the management of chronic hepatitis C].
    Bihl F; Pache I; Hess J; Moradpour D
    Rev Med Suisse; 2010 Jan; 6(233):174, 176-9. PubMed ID: 20214188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C.
    Buti M; San Miguel R; Brosa M; Cabasés JM; Medina M; Angel Casado M; Fosbrook L; Esteban R
    J Hepatol; 2005 May; 42(5):639-45. PubMed ID: 15826711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis C: an age wave of disease burden.
    McHutchison JG; Bacon BR
    Am J Manag Care; 2005 Oct; 11(10 Suppl):S286-95; quiz S307-11. PubMed ID: 16232012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the management of hepatitis C patients appropriate? A population-based study.
    Hatem C; Minello A; Bresson-Hadni S; Jooste V; Evrard P; Obert B; Lepage C; Bonithon-Kopp C; Faivre J; Monnet E; Miguet JP; Hillon P;
    Aliment Pharmacol Ther; 2005 Apr; 21(8):1007-15. PubMed ID: 15813837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economics of chronic hepatitis B and hepatitis C.
    Rajendra A; Wong JB
    J Hepatol; 2007 Oct; 47(4):608-17. PubMed ID: 17697724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C.
    John-Baptiste AA; Tomlinson G; Hsu PC; Krajden M; Heathcote EJ; Laporte A; Yoshida EM; Anderson FH; Krahn MD
    Am J Gastroenterol; 2009 Oct; 104(10):2439-48. PubMed ID: 19568230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of interferon alpha plus ribavirin on health-related quality of life in chronic C hepatitis. The Romanian experience.
    Pojoga C; Dumitraşcu DL; Pascu O; Grigorescu M
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):31-5. PubMed ID: 16680230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of chronic hepatitis C].
    Ferenci P
    Wien Med Wochenschr; 2000; 150(23-24):481-5. PubMed ID: 11205179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
    Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current treatment of chronic hepatitis C].
    Svirtlih N; Simović-Babić J; Krstić M; Delić D
    Srp Arh Celok Lek; 2005; 133(3-4):202-7. PubMed ID: 16206713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: predicting response in hepatitis C virus therapy.
    Mihm U; Herrmann E; Sarrazin C; Zeuzem S
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1043-54. PubMed ID: 16611264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing treatment outcomes in chronic hepatitis C: management of non-response.
    Pol S; Bourlière M
    Antivir Ther; 2006; 11(8):955-70. PubMed ID: 17302365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on the management of hepatitis C.
    Vakil D; McCaughan G
    Aust Fam Physician; 1998 Sep; 27(9):780-6. PubMed ID: 9769524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C.
    Wasmuth HE; Werth A; Mueller T; Berg T; Dietrich CG; Geier A; Gartung C; Lorenzen J; Matern S; Lammert F
    Hepatology; 2004 Aug; 40(2):327-34. PubMed ID: 15368437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How to use virological tools for optimal management of chronic hepatitis C.
    Chevaliez S; Pawlotsky JM
    Liver Int; 2009 Jan; 29 Suppl 1():9-14. PubMed ID: 19207960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.